FDA clears AccuImage's PrimeLung CT (computed tomography) software:
This article was originally published in Clinica
AccuImage Diagnostics' has gained US FDA 510(k) clearance to market its PrimeLung software product for improving the visualisation of lung nodules on CT scans. PrimeLung is configured to reduce operator workload by automating a number of functions, and to increase consistency in measuring nodule characteristics and in following the complex decision tree involved in nodule management, says the San Francisco, California firm.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.